Nursing home study reveals ‘dramatic’ fluctuations in prescribing of COVID-19 meds
By
Alicia Lasek
May 26, 2023
Investigators tracked the use of COVID-19 medications in 11 U.S. nursing home chains, describing prescribing patterns that shed new light on the challenges of pandemic clinical care.
Clinical briefs for Wednesday, Feb. 8
By
Alicia Lasek
Feb 07, 2023
Researchers identify weak links in nursing homes’ COVID defenses … NIH: Early eye injections delay but don’t improve vision loss in diabetic retinopathy … Nearly 4 in 10 U.S. households were sick...
New wave of flu cases, COVID-19 hospitalizations hits U.S., impacting seniors
By
Alicia Lasek
Dec 06, 2022
Flu activity was the highest in a decade last week and hospitalizations for three respiratory viruses are straining healthcare systems, CDC Director Rochelle Walensky said on Monday.
NIH: COVID rebound after Paxlovid may signal a strong immune response
By
Alicia Lasek
Oct 11, 2022
Patients who had rebound symptoms after taking Paxlovid showed a more robust immune response to SARS-CoV-2 than patients with no rebound, investigators reported.
CDC: Two booster shots cut severe COVID risk in nursing home residents by 74 percent
By
Alicia Lasek
Oct 03, 2022
Nursing home residents who received a second mRNA booster shot during omicron were much less likely to suffer severe COVID-19 outcomes than their peers who received only one dose, a new study shows.
High blood pressure plus COVID doubles risk of hospital stay: study
By
Alicia Lasek (f3)
Jul 25, 2022
Even after three COVID-19 vaccine doses, high blood pressure more than doubles the risk for hospitalization with an omicron variant infection, researchers report.
More clinical benefits of molnupiravir ID’d in COVID-19
Jun 07, 2022
New benefits for certain COVID-19 patients, including reduced need for respiratory intervention, have been found for Merck’s COVID-19 pill molnupiravir.
Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.
Burden of persistent symptoms high after COVID-19 infection
May 24, 2022
– A high burden of persistent symptoms is observed in persons after COVID-19, but no specific causes of symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)...
CDC: Turn to Paxlovid to treat COVID-19, not steroids or antibiotics
By
Alicia Lasek (f3)
Apr 26, 2022
The agency is urging clinicians to consider the now readily available, recommended therapies such as Paxlovid as first-line COVID-19 treatments.